Cefepime: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<scene name='10/1040142/Cv/2'>Penicillin-Binding Protein 2X (PBP2X) from Streptococcus pneumoniae in complex with Cefepime</scene> ([[5oj0]]). | <scene name='10/1040142/Cv/2'>Penicillin-Binding Protein 2X (PBP2X) from Streptococcus pneumoniae in complex with Cefepime</scene> ([[5oj0]]). | ||
<scene name='10/1040142/Cv/3'>Cefepime binding site</scene>. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Latest revision as of 16:43, 2 April 2024
Cefepime is a fourth-generation cephalosporin antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. [1] Cefepime. (5oj0). . |
| ||||||||||
ReferencesReferences
- ↑ Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis. 2007 May;7(5):338-48. PMID:17448937 doi:10.1016/S1473-3099(07)70109-3